MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $38,000 | -62.7% | 30,392 | -8.1% | 0.00% | -100.0% |
| Q1 2017 | $102,000 | -29.2% | 33,075 | -6.0% | 0.00% | 0.0% |
| Q4 2016 | $144,000 | -38.7% | 35,175 | -4.8% | 0.00% | -50.0% |
| Q3 2016 | $235,000 | +30.6% | 36,931 | +10.5% | 0.00% | 0.0% |
| Q2 2016 | $180,000 | -40.0% | 33,431 | -6.8% | 0.00% | -33.3% |
| Q1 2016 | $300,000 | +7.9% | 35,881 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $278,000 | -5.4% | 35,216 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | -13.8% | 34,515 | +25.2% | 0.00% | 0.0% |
| Q2 2015 | $341,000 | +76.7% | 27,565 | +69.9% | 0.00% | +50.0% |
| Q1 2015 | $193,000 | – | 16,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |